Literature DB >> 31708358

Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure.

Michele Correale1, Stefania Paolillo2, Valentina Mercurio3, Giuseppe Limongelli4, Francesco Barillà5, Gaetano Ruocco6, Alberto Palazzuoli6, Domenico Scrutinio7, Rocco Lagioia8, Carolina Lombardi9, Laura Lupi10, Damiano Magrì11, Daniele Masarone12, Giuseppe Pacileo12, Pietro Scicchitano13, Marco Matteo Ciccone13, Gianfranco Parati9, Carlo G Tocchetti3, Savina Nodari10.   

Abstract

The increasing number of patients with heart failure HF and comorbidities is due to aging population and increase of life expectancy of patients with cardiovascular disease. Encouraging results derived by recent trials may suggest some comorbidities as new targets for new drugs, highlighting the need for a better understanding of the comorbidities' effects in HF patients and the need of a multidisciplinary approach for the management of chronic HF with comorbidities. We report a brief review about main cardiovascular and non-cardiovascular comorbidities in HF patients in order to update physicians and researchers engaged in the HF research or in "fight against heart failure."
Copyright © 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COPD; Cardio-oncology; Chronic heart failure; Chronic kidney disease; Coronary artery disease; Diabetes; Hypertension; Sleep apnea

Mesh:

Year:  2019        PMID: 31708358     DOI: 10.1016/j.ejim.2019.10.008

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  8 in total

1.  miR-182-5p combined with brain-derived neurotrophic factor assists the diagnosis of chronic heart failure and predicts a poor prognosis.

Authors:  Fang Fang; Xiaonan Zhang; Bin Li; Shouyi Gan
Journal:  J Cardiothorac Surg       Date:  2022-04-30       Impact factor: 1.522

2.  The promise and problems of metabolic-based therapies for heart failure.

Authors:  Dianne M Perez
Journal:  Interv Cardiol (Lond)       Date:  2021-10-04

3.  Recurrent heart failure hospitalizations increase the risk of mortality in heart failure patients with atrial fibrillation and type 2 diabetes mellitus in the United Kingdom: a retrospective analysis of Clinical Practice Research Datalink database.

Authors:  Raquel Lahoz; Ailís Fagan; Martin McSharry; Clare Proudfoot; Stefano Corda; Rachel Studer
Journal:  BMC Cardiovasc Disord       Date:  2022-05-21       Impact factor: 2.174

Review 4.  Direct oral anticoagulants across the heart failure spectrum: the precision medicine era.

Authors:  Stefania Paolillo; Gaetano Ruocco; Pasquale Perrone Filardi; Alberto Palazzuoli; Carlo Gabriele Tocchetti; Savina Nodari; Carlo Lombardi; Marco Metra; Michele Correale
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

Review 5.  Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation.

Authors:  Stefania Paolillo; Angela B Scardovi; Jeness Campodonico
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

6.  Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome.

Authors:  Vincenzo Livio Malavasi; Anna Chiara Valenti; Sara Ruggerini; Marcella Manicardi; Carlotta Orlandi; Daria Sgreccia; Marco Vitolo; Marco Proietti; Gregory Y H Lip; Giuseppe Boriani
Journal:  J Clin Med       Date:  2022-02-08       Impact factor: 4.241

7.  Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study.

Authors:  Rui Valdiviesso; Ana Rita Sousa-Santos; Luís F Azevedo; Emília Moreira; Teresa F Amaral; José Silva-Cardoso; Nuno Borges
Journal:  BMC Cardiovasc Disord       Date:  2022-08-05       Impact factor: 2.174

Review 8.  The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic.

Authors:  Michele Correale; Francesca Croella; Alessandra Leopizzi; Pietro Mazzeo; Lucia Tricarico; Adriana Mallardi; Martino Fortunato; Michele Magnesa; Vincenzo Ceci; Alessandra Puteo; Massimo Iacoviello; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-30       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.